Susquehanna International Group
DYN icon

Susquehanna International Group’s Dyne Therapeutics DYN Stock Holding History

Susquehanna International Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Buy
108,724
+10,509
+11% +$181K ﹤0.01% 6207
2025
Q4 		$1.92M Sell
98,215
-19,555
-17% -$370K ﹤0.01% 5751
2025
Q3 		$1.49M Sell
117,770
-68,245
-37% -$778K ﹤0.01% 6428
2025
Q2 		$1.77M Buy
186,015
+31,661
+21% +$349K ﹤0.01% 6056
2025
Q1 		$1.61M Buy
154,354
+74,840
+94% +$1.07M ﹤0.01% 6029
2024
Q4 		$1.87M Buy
79,514
+46,645
+142% +$1.38M ﹤0.01% 5464
2024
Q3 		$1.18M Buy
32,869
+7,348
+29% +$292K ﹤0.01% 6408
2024
Q2 		$901K Sell
25,521
-415,013
-94% -$12.1M ﹤0.01% 6836
2024
Q1 		$12.5M Buy
440,534
+414,516
+1,593% +$9.37M ﹤0.01% 2317
2023
Q4 		$346K Sell
26,018
-48,030
-65% -$469K ﹤0.01% 9530
2023
Q3 		$663K Buy
74,048
+53,041
+252% +$571K ﹤0.01% 7578
2023
Q2 		$236K Sell
21,007
-29,506
-58% -$348K ﹤0.01% 9932
2023
Q1 		$582K Buy
50,513
+33,489
+197% +$435K ﹤0.01% 8206
2022
Q4 		$197K Sell
17,024
-9,627
-36% -$111K ﹤0.01% 10153
2022
Q3 		$338K Buy
+26,651
New +$306K ﹤0.01% 9480
2021
Q2 		– Sell
-14,682
Closed -$228K – 12689
2021
Q1 		$228K Buy
+14,682
New +$284K ﹤0.01% 11156

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Susquehanna International Group's DYN Position: Q1 2026 in Review

Susquehanna International Group increased its Dyne Therapeutics (DYN) stake by 11% in Q1 2026, buying an estimated $181K and bringing the position to 108,724 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #6207.

Susquehanna International Group first reported a position in DYN in Q1 2021 and has held it in 16 quarters since. The position peaked at $12.5M in Q1 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Susquehanna International Group held 108,724 shares of Dyne Therapeutics worth $1.97M as of Q1 2026.
  • Susquehanna International Group bought 10,509 Dyne Therapeutics shares in Q1 2026, an estimated $181K.
  • Dyne Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6207 holding.
  • Susquehanna International Group first reported a position in Dyne Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Dyne Therapeutics position peaked at $12.5M in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.